Penn Medicine Provider
Pulmonary Medicine
John P. Reilly, MD, MSCE
He, Him, His
Accepting new patients
Sees patients age 18 and up
Harron Lung Center Perelman
Make an appointmentCall 215-615-5864

About me

  • Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania

Education and training

  • Medical School: New York University School of Medicine
  • Residency: NewYork-Presbyterian/Columbia University Medical Center
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital: Has privileges to treat patients in the hospital.
Dr. Reilly is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Reilly JP, Zhao Z, Shashaty MGS, Koyama T, Christie JD, Lanken PN, Wang C, Balmes JR, Matthay MA, Calfee CS, Ware LB. Low to moderate air pollutant exposure and acute respiratory distress syndrome after severe trauma. , American Journal of Respiratory and Critical Care Medicine., 199(1): 2019,62-70

Reilly JP, Wang F, Jones TK, Palakshappa JA, Anderson BJ, Shashaty MGS, Dunn TG, Johannson ED, Riley TR, Lim B, Abbott JA, Ittner CAG, Cantu E, Lin X, Mikacenic C, Wurfel MM, Christiani DC, Calfee CS, Matthay MA, Christie JD, Feng R, Meyer NJ. Plasma angiopoietin-2 as a potential causal marker in sepsis-associated ARDS development: Evidence from mendelian randomization and mediation analysis. , Intensive Care Medicine., 44(11): 2018,1849-1858

Meyer NJ, Reilly JP, Anderson BJ, Palakshappa JA, Dunn T, Shashaty MGS, Feng R, Christie JD, Palardy JE, Opal SM. Mortality benefit of recombinant human interleukin-1 receptor antagonist (rhIL1RA) for sepsis varies by initial IL1RA plasma concentration. , Critical Care Medicine., 46(1): 2018,21-28

Meyer NJ, Reilly JP, Feng R, Christie JD, Hazen SL, Albert CJ, Hartman CL, Franke JD, McHowat J, Ford DA. Myeloperoxidase-derived 2-chlorofatty acids contribute to human sepsis mortality via acute respiratory distress syndrome. , JCI Insight., 2(23): 2017,e96432

Reilly JP, Christie JD Is it possible to prevent ARDS? , Journal of the American Medical Association (JAMA)., 315(22): 2016,2403-2405

Reilly JP, Anderson BJ, Mangalmurti NS, Nguyen TD, Holena DN, Wu Q, Nguyen ET, Reilly MP, Lanken PN, Christie JD, Meyer NJ, Shashaty MGS The ABO histo-blood group and acute kidney injury in critically ill trauma and sepsis patients. , Clinical Journal of the American Society of Nephrology., 10(11): 2015,1911-1920

Zhong M, Zhang H, Reilly JP, Christie JD, Ishihara M, Kumagai T, Azadi P, Reilly MP ABO blood group as a model for platelet glycan modification in arterial thrombosis. , Arteriosclerosis, Thrombosis, and Vascular Biology., 35(7): 2015,1570-1578

Reilly JP, Bellamy S, Shashaty MGS, Gallop R, Meyer NJ, Lanken PN, Kaplan S, Holena DN, May AK, Ware LB, Christie JD Heterogeneous phenotypes of the acute respiratory distress syndrome after major trauma. , Annals of the American Thoracic Society., 11(5): 2014,728-736

Reilly JP, Meyer NJ, Shashaty MGS, Feng R, Lanken PN, Gallop R, Kaplan S, Herlim M, Oz NL, Hiciano I, Campbell A, Holena D, Reilly MP, Christie JD ABO blood type A is associated with increased risk of acute respiratory distress syndrome in whites following both major trauma and severe sepsis. , Chest., 145(4): 2014,753-761

Qing DY, Conegliano D, Shashaty MG, Seo J, Reilly JP, Worthen GS, Huh D, Meyer NJ, Mangalmurti NS RBCs induce necroptosis of lung endothelial cells and increase susceptibility to lung inflammation. , American Journal of Respiratory and Critical Care Medicine., 190(11): 2014,1243-1254